相关实验视频
Updated: Jul 9, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
2型糖尿病质量改善策略对血糖控制的影响:一个元回归分析
Kaveh G Shojania1, Sumant R Ranji, Kathryn M McDonald
1Ottawa Health Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario. kshojania@ohri.ca
JAMA
|July 27, 2006
概括
质量改善策略在2型糖尿病中适度改善了血糖控制. 团队变化和病例管理,特别是药物调整权限,对糖尿病患者显示出最显著的益处.
科学领域:
- 糖尿病管理 糖尿病管理
- 改善医疗保健质量 改善医疗保健质量
- 临床干预 临床干预
背景情况:
- 糖尿病护理质量改善 (QI) 干预措施的有效性尚不清楚.
- 有许多干预措施,但它们对患者结果的影响需要系统评估.
研究的目的:
- 评估11种不同的质量改善 (QI) 策略对2型糖尿病成年人血糖控制的影响.
- 评估各种QI方法在治疗糖尿病中的有效性.
主要方法:
- 随机对照试验,准随机试验和对照前后研究 (共66项试验) 的系统审查和元回归.
- 从MEDLINE和Cochrane协作数据库中提取的数据 (1966年至2006年4月).
- 分析了糖基化血红蛋白 (HbA1c) 值的变化,作为主要结局指标.
主要成果:
- 总体而言,QI干预降低了HbA1c的平均值为0.42%.
- 团队更改 (0.67%的减少) 和案例管理 (0.52%的减少) 显示了最强大的改进.
- 允许病例管理人员在未经医生批准的情况下调整药物的干预措施产生了显著更大的HbA1c降低 (0.80%).
结论:
- 大多数QI策略在血糖控制方面提供了小到适度的改善.
- 团队变更和病例管理是有效的,特别是当病例经理有药物调整自主权时.
- 发表偏见和干预的复杂性可能会影响其他QI策略的估计.
相关概念视频
Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
